Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
About this item
Full title
Author / Creator
Marty, Francisco M , Ljungman, Per , Chemaly, Roy F , Maertens, Johan , Dadwal, Sanjeet S , Duarte, Rafael F , Haider, Shariq , Ullmann, Andrew J , Katayama, Yuta , Brown, Janice , Mullane, Kathleen M , Boeckh, Michael , Blumberg, Emily A , Einsele, Hermann , Snydman, David R , Kanda, Yoshinobu , DiNubile, Mark J , Teal, Valerie L , Wan, Hong , Murata, Yoshihiko , Kartsonis, Nicholas A , Leavitt, Randi Y and Badshah, Cyrus
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
CMV infection is a common complication in patients undergoing hematopoietic-cell transplantation. The incidence of CMV infection was 23 percentage points lower with prophylactic letermovir, a CMV–terminase complex inhibitor, than with placebo, with only low-level toxic effects.
Alternative Titles
Full title
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Authors, Artists and Contributors
Author / Creator
Ljungman, Per
Chemaly, Roy F
Maertens, Johan
Dadwal, Sanjeet S
Duarte, Rafael F
Haider, Shariq
Ullmann, Andrew J
Katayama, Yuta
Brown, Janice
Mullane, Kathleen M
Boeckh, Michael
Blumberg, Emily A
Einsele, Hermann
Snydman, David R
Kanda, Yoshinobu
DiNubile, Mark J
Teal, Valerie L
Wan, Hong
Murata, Yoshihiko
Kartsonis, Nicholas A
Leavitt, Randi Y
Badshah, Cyrus
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_swepub_ki_se_492118
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_492118
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1706640
